PLAT and androgen insensitivity syndrome: We retrospectively analyzed the clinical data of 621 AIS patients who received IVT with recombinant tissue-type plasminogen activator (rt-PA) at the Stroke Centre of the People’s Hospital of Lu’an City, China, from July 2018 to July 2023.